Idiosyncratic drug hepatotoxicity
The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the most frequent cause of post-marketing warnings and withdrawals. This review examines the clinical signatures of this problem, signals predictive of its occurrence (particularly of more frequent, reversible, low-grade injury) and the role of monitoring in prevention by examining several recent examples (for example, troglitazone). In addition, the failure of preclinical toxicology to predict idiosyncratic reactions, and what can be done to improve this problem, is discussed. Finally, our current understanding of the pathophysiology of experimental drug hepatotoxicity is examined, focusing on acetaminophen, particularly with respect to the role of the innate immune system and control of cell-death pathways, which might provide targets for exploration and identification of risk factors and mechanisms in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [2]
In the citing paper
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [1]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Research works printed but not linked: 3
- Nelson, S. D. & Bruschi, S. A. in Drug-Induced Liver Disease (eds Kaplowitz, N. & DeLeve, L.) 287–325 (Marcel Dekker, New York, 2003).
- Chien, J. Y., Thummel, K. E. & Slattery, J. T. Pharmakinetic consequence of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165–1175 (1997).
- Liu, Z. -X. & Kaplowitz, N. in Clinics in Liver Disease 6, 467–486 (Elsevier, 2002).
Cited by
Items 201–300 of 999
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury
García- Cañaveras, J. C., Castell, J. V., Donato, M. T., & Lahoz, A. (2016) · Scientific Reports · doi:10.1038/srep27239 · Cited by 80
Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures
Weng, Y., Chang, S., Shih, M., Tseng, S., & Lai, C. (2017) · Advanced Materials · doi:10.1002/adma.201701545 · Cited by 79
Structure–Activity Relationships for In vitro and In vivo Toxicity
Blagg, J. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41024-1 · Cited by 79
An Overview on the Proposed Mechanisms of Antithyroid Drugs-Induced Liver Injury
Heidari, R., Niknahad, H., Jamshidzadeh, A., Eghbal, M. A., & Abdoli, N. (2015) · PubMed Central · doi:10.5681/apb.2015.001 · Cited by 88
Beyer, R. P., Fry, R. C., Lasarev, M. R., McConnachie, L. A., Meira, L. B., Palmer, V. S., Powell, C. L., Ross, P. K., Bammler, T. K., Bradford, B. U., et al. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm150 · Cited by 88
The Nuremberg Code subverts human health and safety by requiring animal modeling
Greek, R., Pippus, A., & Hansen, L. A. (2012) · BMC Medical Ethics · doi:10.1186/1472-6939-13-16 · Cited by 78
Zhang, J., Jin, Z., Hu, X., Meng, H., Li, J., Zhang, X., Liu, H., Deng, T., Yao, S., & Feng, L. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01659 · Cited by 80
Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China
Zhu, L., Zhang, C., Li, D.-P., Chen, H., Ma, J., Gao, H., Ye, Y., Wang, J.-Y., Fu, P. P., & Lin, G. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00553-9 · Cited by 84
Assessment of drug‐induced liver injury in clinical practice
Isabel Lucena, M., García‐Cortés, M., Cueto, R., Lopez‐Duran, J., & Andrade, R. J. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00566.x · Cited by 78
Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance
Steuerwald, N. M., Foureau, D. M., Norton, H. J., Zhou, J., Parsons, J. C., Chalasani, N., Fontana, R. J., Watkins, P. B., Lee, W. M., Reddy, K. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081974 · Cited by 76
Stem Cells for Next Level Toxicity Testing in the 21st Century
Fritsche, E., Haarmann‐Stemmann, T., Kapr, J., Galanjuk, S., Hartmann, J., Mertens, P. R., Kämpfer, A. A. M., Schins, R. P. F., Tigges, J., & Koch, K. (2021) · Small · doi:10.1002/smll.202006252 · Cited by 75
Shangguan, L., Wang, J., Qian, X., Wu, Y., & Liu, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02431 · Cited by 75
Zhu, X., & Kruhlak, N. L. (2014) · Toxicology · doi:10.1016/j.tox.2014.03.009 · Cited by 78
Next-Generation Liver Medicine Using Organoid Models
Akbari, S., Arslan, N., Senturk, S., & Erdal, E. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00345 · Cited by 72
“Metabolically, it is divided into different structural zones and functional organizations (Kietzmann, 2017).”
BackgroundStem cell‐derived hepatocytes as a predictive model for drug‐induced liver injury: are we there yet?
Kia, R., Sison, R. L. C., Heslop, J., Kitteringham, N. R., Hanley, N., Mills, J. S., Park, B. K., & Goldring, C. E. P. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04360.x · Cited by 74
Cai, C., Ma, H., Peng, J., Shen, X., Zhen, X., Yu, C., Zhang, P., Ji, F., & Wang, J. (2023) · Nature Communications · doi:10.1038/s41467-023-39412-6 · Cited by 80
Longo, D., Yang, Y., Watkins, P., Howell, B., & Siler, S. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12053 · Cited by 73
Zheng, J., Wu, Y., Xing, D., & Zhang, T. (2019) · Nano Research · doi:10.1007/s12274-019-2327-6 · Cited by 72
ADMET Profiling of Geographically Diverse Phytochemical Using Chemoinformatic Tools
Fatima, S., Gupta, P., Sharma, S., Sharma, A., & Agarwal, S. M. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0206 · Cited by 81
Cell based approaches for evaluation of drug-induced liver injury
Greer, M. L., Barber, J., Eakins, J. A., & Kenna, J. G. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.007 · Cited by 73
Mitochondrial involvement in drug-induced hepatic injury
Kass, G. E. N. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.06.007 · Cited by 78
Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
Pachkoria, K., Lucena, M. I., Crespo, E., Ruiz‐Cabello, F., López-Ortega, S., Fernández‐Santaella, M. C., Romero‐Gómez, M., Madrazo, A., Durán, J. A., de Dios, A. M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.017 · Cited by 80
Lou, H., & Kaplowitz, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706145200 · Cited by 75
Self-citationHe, S., Zhang, C., Zhou, P., Zhang, X., Ye, T., Wang, R., Sun, G., & Sun, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153633 · Cited by 75
Toxicophores: Investigations in drug safety
Williams, D. P. (2006) · Toxicology · doi:10.1016/j.tox.2006.05.101 · Cited by 78
Martin, H. L., Adams, M., Higgins, J. W., Bond, J., Morrison, E. E., Bell, S. M., Warriner, S. L., Nelson, A. S., & Tomlinson, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088338 · Cited by 79
Satapornpong, P., Jinda, P., Jantararoungtong, T., Koomdee, N., Chaichan, C., Pratoomwun, J., Nakorn, C. N., Aekplakorn, W., Wilantho, A., Ngamphiw, C., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00078 · Cited by 83
Raschi, E., Poluzzi, E., Koci, A., Caraceni, P., & Ponti, F. D. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i8.601 · Cited by 71
Hepatocellular toxicity of benzbromarone: Effects on mitochondrial function and structure
Felser, A., Lindinger, P. W., Schnell, D., Kratschmar, D. V., Odermatt, A., Mies, S., Jenö, P., & Krähenbühl, S. (2014) · Toxicology · doi:10.1016/j.tox.2014.08.002 · Cited by 78
Searching for a Needle in a Haystack: Use of ICD-9-CM Codes in Drug-Induced Liver Injury
Jinjuvadia, K., Kwan, W., & Fontana, R. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01456.x · Cited by 71
Factors affecting drug-induced liver injury: antithyroid drugs as instances
Heidari, R., Niknahad, H., Jamshidzadeh, A., & Abdoli, N. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.3.237 · Cited by 73
Hepatotoxic Botanicals - An Evidence-based Systematic Review
Abdualmjid, R. J., & Sergi, C. (2013) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j36g6x · Cited by 70
Ozer, J. S., Chetty, R., Kenna, J. G., Palandra, J., Zhang, Y., Lanevschi, A., Koppiker, N., Souberbielle, B. E., & Ramaiah, S. K. (2009) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.11.001 · Cited by 72
Oxidative and Non-Oxidative Metabolomics of Ethanol
J. Dinis-Oliveira, R. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160125113806 · Cited by 69
Ma, J., Li, Y., Wu, M., Zhang, C., Che, Y., Li, W., & Li, X. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.02.046 · Cited by 70
Yee, S. B., Bourdi, M., Masson, M. J., & Pohl, L. R. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600349f · Cited by 68
High throughput direct 3D bioprinting in multiwell plates
Hwang, H. H., You, S., Ma, X., Kwe, L., Victorine, G., Lawrence, N., Wan, X., Shen, H., Zhu, W. Z., & Chen, S. (2021) · Biofabrication · doi:10.1088/1758-5090/ab89ca · Cited by 77
Adverse Drug Reactions in Women's Health Care
Tharpe, N. (2011) · Journal of Midwifery & Women's Health · doi:10.1111/j.1542-2011.2010.00050.x · Cited by 64
Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods
Ford, K. A. (2016) · ILAR Journal · doi:10.1093/ilar/ilw031 · Cited by 72
Pharmacogenetics of Adverse Drug Reactions
Osanlou, O., Pirmohamed, M., & Daly, A. K. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.002 · Cited by 76
Hong, X., Tang, H., Wu, L., & Lian-da, L. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.10.0013 · Cited by 73
Ueda, K., Ishitsu, T., Seo, T., Ueda, N., Murata, T., Hori, M., & Nakagawa, K. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.5.435 · Cited by 66
Idiosyncratic drug-induced liver injury: an update on the 2007 overview
Hussaini, S. H., & Farrington, E. A. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.828032 · Cited by 66
Human embryonic stem cells: a journey beyond cell replacement therapies
Menéndez, P. R., Bueno, C., & Wang, L. (2006) · Cytotherapy · doi:10.1080/14653240601026654 · Cited by 77
Amoxicillin and amoxicillin plus clavulanate: a safety review
Salvo, F., Sarro, A. D., Caputi, A. P., & Polimeni, G. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330802527984 · Cited by 85
Microengineered Bioartificial Liver Chip for Drug Toxicity Screening
Delalat, B., Cozzi, C., Ghaemi, S. R., Polito, G., Kriel, F. H., Michl, T. D., Harding, F. J., Priest, C., Barillaro, G., & Voelcker, N. H. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801825 · Cited by 70
Prill, S., Bavli, D., Levy, G., Tsur, E. E., Schmälzlin, E., Jaeger, M. S., Schwarz, M., Duschl, C., Cohen, M., & Nahmias, Y. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1537-2 · Cited by 70
Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes
Michailidis, E., Vercauteren, K., Mâncio-Silva, L., Andrus, L., Jahan, C., Ricardo-Lax, I., Zou, C., Kabbani, M., Park, P., Quirk, C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919035117 · Cited by 66
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Teo, Y. L., Ho, H. K., & Chan, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.983075 · Cited by 64
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
Herpers, B., Wink, S., Fredriksson, L., Di, Z., Hendriks, G., Vrieling, H., de Bont, H., & van de Water, B. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1536-3 · Cited by 67
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns
Meanwell, N. A., Wallace, O. B., Fang, H., Wang, H., Deshpande, M., Wang, T., Yin, Z., Zhang, Z., Pearce, B. C., James, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.040 · Cited by 62
Muller, P. Y., & Dieterle, F. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903114174 · Cited by 62
Tak, J., Kim, Y. S., Kim, T. H., Park, G., Hwang, S., & Kim, S. G. (2022) · Theranostics · doi:10.7150/thno.67722 · Cited by 64
Chen, M., Tung, C.-W., Shi, Q., Guo, L., Shi, L. M., Fang, H., Borlak, J. T., & Tong, W. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1276-9 · Cited by 69
Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism
Tuschl, G., Lauer, B., & Mueller, S. O. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.855 · Cited by 62
Yang, X., Schnackenberg, L. K., Shi, Q., & Salminen, W. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00013-0 · Cited by 71
Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases
Fiorotto, R., Amenduni, M., Mariotti, V., Fabris, L., Spirli, C., & Strazzabosco, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.038 · Cited by 62
Long‐Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures
Ukairo, O., Kanchagar, C., Moore, A., Shi, J., Gaffney, J., Aoyama, S., Rose, K., Krzyzewski, S., McGeehan, J., Andersen, M. E., et al. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21469 · Cited by 61
Nonsteroidal Anti-Inflammatory Drug–Induced Hepatoxicity
Unzueta, A., & Vargas, H. E. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.009 · Cited by 66
Bioaccumulation and Subchronic Toxicity of 14 nm Gold Nanoparticles in Rats
Rambanapasi, C., Zeevaart, J. R., Buntting, H., Bester, C. J., Kotze, D., Hayeshi, R. K., & Grobler, A. (2016) · Molecules · doi:10.3390/molecules21060763 · Cited by 65
Thakkar, S., chen, M., Fang, H., Liu, Z., Roberts, R., & Tong, W. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1383154 · Cited by 61
Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies
Hornberg, J. J., Laursen, M., Brenden, N., Persson, M., Thougaard, A., Toft, D. B., & Mow, T. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.009 · Cited by 65
Organs on microfluidic chips: A mini review
Jiang, B., Zheng, W., Zhang, W., & Jiang, X. (2013) · Science China Chemistry · doi:10.1007/s11426-013-4971-0 · Cited by 62
Atienzar, F. A., Blomme, E. A., Chen, M., Hewitt, P., Kenna, J. G., Labbe, G., Moulin, F., Pognan, F., Roth, A. B., Suter-Dick, L., et al. (2016) · BioMed Research International · doi:10.1155/2016/9737920 · Cited by 59
Watkins, P. B., Dubé, L. M., Walton-Bowen, K. L., CAMERON, C. M., & Kasten, L. E. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00006 · Cited by 62
The potential of cytokines as safety biomarkers for drug-induced liver injury
Laverty, H., Antoine, D. J., Benson, C. A., Chaponda, M., Williams, D. P., & Park, B. K. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0862-x · Cited by 64
Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity
Agúndez, J. A. G., Lucena, M. I., Martínez, C., Andrade, R. J., Blanca, M., Ayuso, P., & García‐Martín, E. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.574613 · Cited by 59
Pregnane X receptor and drug-induced liver injury
Wang, Y., Chai, S. C., Brewer, C., & Chen, T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.963555 · Cited by 68
Cytokine-associated drug toxicity in human hepatocytes is associated signaling network dysregulation
Hendriks, B. S., Cosgrove, B. D., Alexopoulos, L. G., Hang, T.-C., Sorger, P. K., Griffith, L. G., & Lauffenburger, D. A. (2009) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 59
Goldring, C., Antoine, D. J., Bonner, F., Crozier, J., Denning, C., Fontana, R. J., Hanley, N. A., Hay, D. C., Ingelman‐Sundberg, M., Juhila, S., et al. (2017) · Hepatology · doi:10.1002/hep.28886 · Cited by 58
dos Santos, N. A. G., Medina, W. S. G., Martins, N. M., Mingatto, F. E., Curti, C., & dos Santos, A. C. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.03.004 · Cited by 58
Zhang, M., Chen, M., & Tong, W. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200320e · Cited by 58
Current Challenges and Controversies in Drug-Induced Liver Injury
Corsini, A., Ganey, P. E., Ju, C., Kaplowitz, N., Pessayre, D., Roth, R. A., Watkins, P. B., Albassam, M., Liu, B., Stancic, S., et al. (2012) · Drug Safety · doi:10.1007/bf03261997 · Cited by 63
Self-citationKaplowitz, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00001-7 · Cited by 61
Self-citationThinking Inside the Box: Keeping Tissue-Engineered Constructs In Vitro for Use as Preclinical Models
Gibbons, M. C., Foley, M. A., & Cardinal, K. O. (2012) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2012.0305 · Cited by 64
Zou, W., Beggs, K. M., Sparkenbaugh, E., Jones, A. D., Younis, H. S., Roth, R. A., & Ganey, P. E. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.156331 · Cited by 60
Troglitazone Hepatotoxicity: Are We Getting Closer to Understanding Idiosyncratic Liver Injury?
Jaeschke, H. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm021 · Cited by 55
Hirano, H., Kurata, A., Onishi, Y., Sakurai, A., Saito, H., Nakagawa, H., Nagakura, M., Tarui, S., Kanamori, Y., Kitajima, M., et al. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060004w · Cited by 59
The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results
McBurney, R. N., Hines, W. M., Tungeln, L. S. V., Schnackenberg, L. K., Beger, R. D., Moland, C. L., Han, T., Fuscoe, J. C., Chang, C., Chen, J. J., et al. (2009) · Toxicologic Pathology · doi:10.1177/0192623308329287 · Cited by 57
Genetics and Treatment Response in Parkinson’s Disease: An Update on Pharmacogenetic Studies
Politi, C., Ciccacci, C., Novelli, G., & Borgiani, P. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8473-7 · Cited by 61
Ahmad, M. M., Rezk, N. A., Fawzy, A., & Sabry, M. A. (2019) · Gene · doi:10.1016/j.gene.2019.143966 · Cited by 56
HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications.
Andreoni, M., Giacometti, A., Maida, I. R., Meraviglia, P., Ripamonti, D., & Sarmati, L. (2012) · PubMed · Cited by 67
Hadi, M., Westra, I. M., Starokozhko, V., Dragovic, S., Merema, M. T., & Groothuis, G. M. M. (2013) · Chemical Research in Toxicology · doi:10.1021/tx300519p · Cited by 55
Stieger, B., & Geier, A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.557067 · Cited by 59
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
Iasella, C. J., Johnson, H. J., & Dunn, M. A. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.005 · Cited by 71
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667010 · Cited by 54
Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs
dos Santos, N. A. G., Medina, W. S. G., Martins, N. M., Rodrigues, M. A. C., Curti, C., & dos Santos, A. C. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.08.004 · Cited by 62
In Vitro Cytotoxicity Assessment
O'Brien, P. J., & Haskins, J. R. (2006) · Humana Press eBooks · doi:10.1385/1-59745-217-3:415 · Cited by 54
Lee, Y. H., Chung, M. C. M., Lin, Q., & Boelsterli, U. A. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.025 · Cited by 55
Anti-Parkinson's disease drugs and pharmacogenetic considerations
Agúndez, J. A. G., García‐Martín, E., Alonso‐Navarro, H., & Jiménez‐Jiménez, F. J. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.789018 · Cited by 56
Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road
Treinen–Moslen, M., & Kanz, M. F. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.007 · Cited by 56
Cui, J., Wang, H., Zheng, Z., Shi, Q., Sun, T., Huang, Q., & Fukuda, T. (2018) · Biofabrication · doi:10.1088/1758-5090/aaf3c9 · Cited by 54
Alamri, R. D., Elmeligy, M. A., Albalawi, G. A., Alquayr, S. M. A., Alsubhi, S. S., & El-Ghaiesh, S. H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107398 · Cited by 61
Mechanisms of drug induced liver injury
Skat‐Rørdam, J., Lykkesfeldt, J., Gluud, L. L., & Tveden‐Nyborg, P. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05744-3 · Cited by 69
Toxicology and Safety of Comt Inhibitors
Haasio, K. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-381326-8.00007-7 · Cited by 58
“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects
Lin, H., Ewing, L., Koturbash, I., Gurley, B. J., & Miousse, I. R. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.10.026 · Cited by 61
Metadata
- Authors
- Kaplowitz, N.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Kaplowitz, Neil
- ORCID
- Kaplowitz, Neil
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-06
- Volume
- 4
- Issue
- 6
- Pages
- 489-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017783406
- Cited by
- 1,054
- References
- 155
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 31 · 2021: 49 · 2020: 45 · 2019: 48 · 2018: 54 · 2017: 66 · 2016: 72 · 2015: 55 · 2014: 64 · 2013: 57 · 2012: 52
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, troglitazone, preclinical toxicology, hepatotoxicity prediction, pharmacovigilance, acetaminophen hepatotoxicity, innate immune system, cell death pathways, drug withdrawal, post-marketing surveillance
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, Liver Diseases, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.